Effect of filgrastim on serum lactate dehydrogenase and alkaline phosphatase values in early breast cancer patients

Cancer Investigation

Volumn 22, Issue 4, 2004, Pages 650-653

  Papaldo, Paola ^a   Di Cosimo, Serena ^a   Ferretti, Gianluigi ^a   Vici, Patrizia ^a   Marolla, Paolo ^a   Carlini, Paolo ^a   Fabi, Alessandra ^a   Cognetti, Francesco ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

AP; Breast cancer; G CSF; LDH

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; CYCLOPHOSPHAMIDE; EPIRUBICIN; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; GASTROINTESTINAL TOXICITY; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; LEUKOCYTOSIS; LIVER INJURY; MAJOR CLINICAL STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ALKALINE PHOSPHATASE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CLINICAL TRIALS, PHASE II; FILGRASTIM; HUMANS; L-LACTATE DEHYDROGENASE; RANDOMIZED CONTROLLED TRIALS;

EID: 8644269489     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-200027175     Document Type: Article

References (8)

1. Menekay, S.; Ozsan, G.H.; Demirkan, F.; Ozbek, D.; Ozean, M.A.; Fadiloglu, M.; Undar, B. Effect of granulocyte-colony-stimulating factor on serum lactate dehydrogenase levels and isoenzymes in a rabbit model. Acta Haematol. 2002, 107 (1), 18-22.
2. Watanabe, T.; Suzuya, H.; Onishi, T.; Kanai, S.; Kaneko, M.; Watanabe, H.; Nakagawa, R.; Kawano, Y.; Takaue, Y.; Kuroda, Y.; Talmadge, J.E. Effect of granulocyte colony-stimulating factor on bone metabolism during peripheral blood stem cell mobilization. Int. J. Hematol. 2003, 77, 75-81.
3. Fossa, S.D.; Poulsen, J.P.; Aaserud, A. Alkaline phospatase and lactate dehydrogenase changes during leucocytosis induced by G-CSF in testicular cancer. The Lancet 1992, 340, 1544.
4. Maiche, A.G.; Muhonen, T.; Porkka, K. Lactate dehydrogenase changes during granulocyte colony-stimulating factor treatment. The Lancet 1992, 340, 853.
5. Fukumasu, H.; Fukumasu, Y.; Ogita, S. Elevation in plasma alkaline phosphatase level during rhG-CSF administration. Granulocytopenic patients with gynecologic cancers treated with cancer chemotherapy. Gynecol. Obstet. Invest. 1998, 45 (2), 99-104.
6. Shiraishi, K.; Sugita, K.; Inukai, T.; Iijima, K.; Tezuka, T.; Goi, K.; Kojika, S.; Nakazawa, S. Analysis of serum lactate dehydrogenase and its isozymes during administration of granulocyte colony-stimulating factor in children. Int J Hematol. Aug 2000, 72 (2), 194-199.
7. Sarris, A.H.; Majlis, A.; Dimopoulos, M.A.; Younes, A.; Swann, F.; Rodriguez, M.A.; McLaughlin, P.; Cabanillas, F. Rising serum lactate dehydrogenase often caused by granulocyte- or granulocyte-macrophage colony stimulating factor and not tumor progression in patients with lymphoma or myeloma. Leuk. Lymphoma May 1995, 17 (5-6), 473-477.
8. Akizuki, S.; Mizorogi, F.; Inoue, T.; Sudo, K.; Ohnishi, A. Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects. Bone Marrow Transplant. Nov 2000, 26 (9), 939-946.